Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) FCF Margin (2019 - 2025)

Bioadaptives' FCF Margin history spans 7 years, with the latest figure at 1494.47% for Q4 2025.

  • Quarterly results put FCF Margin at 1494.47% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 2823.2% (down 85369.0% YoY), and the annual figure for FY2025 was 2921.68%, down 95217.0%.
  • FCF Margin for Q4 2025 was 1494.47% at Bioadaptives, up from 3266.6% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 343.35% in Q1 2024 to a low of 7623.11% in Q2 2024.
  • The 5-year median for FCF Margin is 1267.82% (2023), against an average of 1741.09%.
  • The sharpest move saw FCF Margin tumbled -519186bps in 2024, then skyrocketed 417539bps in 2025.
  • Year by year, FCF Margin stood at 919.32% in 2021, then increased by 25bps to 690.36% in 2022, then plummeted by -84bps to 1267.82% in 2023, then crashed by -501bps to 7623.11% in 2024, then soared by 80bps to 1494.47% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 1494.47%, 3266.6%, and 3447.72% for Q4 2025, Q3 2025, and Q2 2025 respectively.